FDA Approves New Blood Test for Colon Cancer

The U.S. Food and Drug Administration (FDA) has approved a new blood test for colorectal cancer (CRC) screening for use in adults aged 45 and older who are at average risk for the disease, according to a statement from Guardant Health Inc. The FDA’s decision follows a strong recommendation for approval from an advisory committee panel in May 2024. The approval of Guardant Health’s “Shield” test marks the first time a blood test has been recognized by the FDA as a primary screening option for CRC, offering a noninvasive alternative to traditional methods such as colonoscopies and stool-based tests, according to the statement....